|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast R&D Day Presentation
|
|
Pazy1
|
295 |
93K |
12 |
09/04/26 |
| 09/04/26 |
ASX - By Stock
|
295
|
93K
|
12
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pazy1
|
21K |
7.7M |
2 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
21K
|
7.7M
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pazy1
|
21K |
7.7M |
10 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
21K
|
7.7M
|
10
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pazy1
|
21K |
7.7M |
1 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
21K
|
7.7M
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pazy1
|
21K |
7.7M |
1 |
02/03/26 |
| 02/03/26 |
ASX - By Stock
|
21K
|
7.7M
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Corporate Presentation and Half Year Financial Results
|
|
Pazy1
|
87 |
32K |
3 |
02/03/26 |
| 02/03/26 |
ASX - By Stock
|
87
|
32K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2026 Half Year Financial Results Webcast
|
|
Pazy1
|
67 |
29K |
7 |
20/02/26 |
| 20/02/26 |
ASX - By Stock
|
67
|
29K
|
7
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: High Survival Rates with Ryoncil in SR-aGvHD EIND Program
|
|
Pazy1
|
112 |
34K |
1 |
12/02/26 |
| 12/02/26 |
ASX - By Stock
|
112
|
34K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: High Survival Rates with Ryoncil in SR-aGvHD EIND Program
|
|
Pazy1
|
112 |
34K |
7 |
12/02/26 |
| 12/02/26 |
ASX - By Stock
|
112
|
34K
|
7
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: High Survival Rates with Ryoncil in SR-aGvHD EIND Program
|
|
Pazy1
|
112 |
34K |
5 |
12/02/26 |
| 12/02/26 |
ASX - By Stock
|
112
|
34K
|
5
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: High Survival Rates with Ryoncil in SR-aGvHD EIND Program
|
|
Pazy1
|
112 |
34K |
23 |
12/02/26 |
| 12/02/26 |
ASX - By Stock
|
112
|
34K
|
23
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Becoming a substantial holder
|
|
Pazy1
|
47 |
16K |
1 |
09/02/26 |
| 09/02/26 |
ASX - By Stock
|
47
|
16K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Becoming a substantial holder
|
|
Pazy1
|
47 |
16K |
6 |
09/02/26 |
| 09/02/26 |
ASX - By Stock
|
47
|
16K
|
6
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Pazy1
|
87 |
29K |
13 |
29/01/26 |
| 29/01/26 |
ASX - By Stock
|
87
|
29K
|
13
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Pazy1
|
87 |
29K |
16 |
29/01/26 |
| 29/01/26 |
ASX - By Stock
|
87
|
29K
|
16
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Real World Experience with Ryoncil Shows 84% Early Survival
|
|
Pazy1
|
126 |
38K |
24 |
27/01/26 |
| 27/01/26 |
ASX - By Stock
|
126
|
38K
|
24
|
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast dips on confusion around FDA advice on stem cells for back pain
|
|
Pazy1
|
93 |
25K |
2 |
19/01/26 |
| 19/01/26 |
ASX - By Stock
|
93
|
25K
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Lyn Cobley
|
|
Pazy1
|
25 |
10K |
7 |
12/01/26 |
| 12/01/26 |
ASX - By Stock
|
25
|
10K
|
7
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Warrant Prospectus Related to Convertible Note Agreements
|
|
Pazy1
|
14 |
6.7K |
3 |
16/12/25 |
| 16/12/25 |
ASX - By Stock
|
14
|
6.7K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
MSB CEO Answer to Diabetes Question at AGM
|
|
Pazy1
|
2 |
1.2K |
17 |
05/12/25 |
| 05/12/25 |
ASX - By Stock
|
2
|
1.2K
|
17
|
|
|
ASX - By Stock
|
MSB |
Re:
BP Healthcare Conference 20-11-25
|
|
Pazy1
|
180 |
51K |
3 |
23/11/25 |
| 23/11/25 |
ASX - By Stock
|
180
|
51K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
BP Healthcare Conference 20-11-25
|
|
Pazy1
|
180 |
51K |
8 |
21/11/25 |
| 21/11/25 |
ASX - By Stock
|
180
|
51K
|
8
|
|
|
ASX - By Stock
|
MSB |
Re:
BP Healthcare Conference 20-11-25
|
|
Pazy1
|
180 |
51K |
8 |
21/11/25 |
| 21/11/25 |
ASX - By Stock
|
180
|
51K
|
8
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appointment of Chief Financial Officer
|
|
Pazy1
|
113 |
37K |
3 |
18/11/25 |
| 18/11/25 |
ASX - By Stock
|
113
|
37K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appointment of Chief Financial Officer
|
|
Pazy1
|
113 |
37K |
4 |
18/11/25 |
| 18/11/25 |
ASX - By Stock
|
113
|
37K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appointment of Chief Financial Officer
|
|
Pazy1
|
113 |
37K |
6 |
18/11/25 |
| 18/11/25 |
ASX - By Stock
|
113
|
37K
|
6
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appointment of Chief Financial Officer
|
|
Pazy1
|
113 |
37K |
12 |
17/11/25 |
| 17/11/25 |
ASX - By Stock
|
113
|
37K
|
12
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pazy1
|
21K |
7.7M |
9 |
16/10/25 |
| 16/10/25 |
ASX - By Stock
|
21K
|
7.7M
|
9
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pazy1
|
21K |
7.7M |
3 |
16/10/25 |
| 16/10/25 |
ASX - By Stock
|
21K
|
7.7M
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
$3 Party
|
|
Pazy1
|
283 |
107K |
1 |
09/10/25 |
| 09/10/25 |
ASX - By Stock
|
283
|
107K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
$3 Party
|
|
Pazy1
|
283 |
107K |
0 |
09/10/25 |
| 09/10/25 |
ASX - By Stock
|
283
|
107K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
$3 Party
|
|
Pazy1
|
283 |
107K |
4 |
09/10/25 |
| 09/10/25 |
ASX - By Stock
|
283
|
107K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
$3 Party
|
|
Pazy1
|
283 |
107K |
43 |
09/10/25 |
| 09/10/25 |
ASX - By Stock
|
283
|
107K
|
43
|
|
|
ASX - By Stock
|
MSB |
Re:
$3 Party
|
|
Pazy1
|
283 |
107K |
19 |
08/10/25 |
| 08/10/25 |
ASX - By Stock
|
283
|
107K
|
19
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ryoncil Revenues Increase 66% in Second Quarter Post Launch
|
|
Pazy1
|
218 |
78K |
15 |
07/10/25 |
| 07/10/25 |
ASX - By Stock
|
218
|
78K
|
15
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ceasing to be a substantial holder
|
|
Pazy1
|
58 |
18K |
3 |
22/09/25 |
| 22/09/25 |
ASX - By Stock
|
58
|
18K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ceasing to be a substantial holder
|
|
Pazy1
|
58 |
18K |
3 |
22/09/25 |
| 22/09/25 |
ASX - By Stock
|
58
|
18K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pazy1
|
21K |
7.7M |
2 |
10/09/25 |
| 10/09/25 |
ASX - By Stock
|
21K
|
7.7M
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pazy1
|
21K |
7.7M |
3 |
10/09/25 |
| 10/09/25 |
ASX - By Stock
|
21K
|
7.7M
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pazy1
|
21K |
7.7M |
8 |
04/09/25 |
| 04/09/25 |
ASX - By Stock
|
21K
|
7.7M
|
8
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pazy1
|
21K |
7.7M |
4 |
04/09/25 |
| 04/09/25 |
ASX - By Stock
|
21K
|
7.7M
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Option to Issue up to US$50m Convertible Notes
|
|
Pazy1
|
138 |
47K |
9 |
04/09/25 |
| 04/09/25 |
ASX - By Stock
|
138
|
47K
|
9
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pazy1
|
21K |
9.0M |
7 |
02/09/25 |
| 02/09/25 |
ASX - By Stock
|
21K
|
9.0M
|
7
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pazy1
|
21K |
9.0M |
15 |
02/09/25 |
| 02/09/25 |
ASX - By Stock
|
21K
|
9.0M
|
15
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
Pazy1
|
3.2K |
1.3M |
3 |
01/09/25 |
| 01/09/25 |
ASX - By Stock
|
3.2K
|
1.3M
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Financial Results Presentation
|
|
Pazy1
|
321 |
99K |
4 |
29/08/25 |
| 29/08/25 |
ASX - By Stock
|
321
|
99K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pazy1
|
21K |
7.7M |
2 |
27/08/25 |
| 27/08/25 |
ASX - By Stock
|
21K
|
7.7M
|
2
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pazy1
|
21K |
7.7M |
1 |
26/08/25 |
| 26/08/25 |
ASX - By Stock
|
21K
|
7.7M
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pazy1
|
21K |
7.7M |
1 |
26/08/25 |
| 26/08/25 |
ASX - By Stock
|
21K
|
7.7M
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ceasing to be a substantial holder
|
|
Pazy1
|
7 |
3.8K |
9 |
25/08/25 |
| 25/08/25 |
ASX - By Stock
|
7
|
3.8K
|
9
|
|